For the latest updates on how we are managing changes due to COVID-19 please click here. The world’s leading, full-service ophthalmic research organization Think Ophthalmology. Think Ora. Learn More About What We Do Accelerate Your Product Development The vision and experience to guide your product development 52 Product approvals 100% Therapeutic Area Leaders with 15+ years of ophthalmic experience 96% Clinical Project Managers with 5+ years of experience 92% Clinical Monitors with 5+ years of experience 1,600+ Clinical studies and consulting projects 320+ Employees across 16 different countries Our Services Therapeutic Areas Ocular Surface and Anterior Segment Ora is accelerating research for indications including dry eye, allergy, and inflammation. Learn More Posterior Segment Ora is advancing research to address vision-altering indications from inherited retinal diseases (IRDs) to other retina conditions. Learn More Ophthalmic Devices Ora supports the development of marketed products through the conduct of clinical trials, regulatory consulting, and more. Learn More CRO Services Preclinical Ora’s ophthalmic experts are ready to collaborate with you at the early stages of product development, providing the milestone data you need to make important decisions. Learn More Clinical Our unique focus on ophthalmology drives our expert approach to Clinical Operations, with services across the clinical development continuum and the globe. Learn More CMC & Regulatory Ora offers CMC consulting, as well as international regulatory strategy, representation, writing, and electronic submissions. Learn More Patient and Site Solutions Our exclusive networks connect you with high-quality investigators and patients, helping you drastically accelerate recruitment. Learn More Jim McCollum, Eye Therapies “The idea is you partner with the leading experts in the world and the Ora team are experts in this area, so for us it was kind of a no brainer to sit with them and map out the plan.” Recent News September, 2021 Editas Medicine Announces Positive Initial Clinical Data from Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10 Read More April, 2021 Ora Appoints David P. Bingaman, DVM, PhD, D. ACVO in Newly Created Chief Development Officer Position Read More Upcoming Events May, 2021 Keynote: 2021 International Congress of Ophthalmology and Optometry China October, 2020 Understanding the Challenges and Innovations in Ophthalmic Gene Therapy Research July, 2020 The Benefits and Acceptance of Technology-Enabled Operations in Ophthalmic Clinical Research April, 2020 Innovating for Unmet Needs in the Posterior Segment February, 2020 The Opportunities and Challenges of Repurposing Systemic Drugs for Ocular Indications November, 2019 The Ora-CAC® Model: Evaluating the Efficacy of Anti-Allergic and Anti-Inflammatory Products August, 2019 Ora’s Site & Patient Network: Optimizing Patient Recruitment August, 2019 How the Regulator’s View of AI is Unfolding in the US: A Lens on Ophthalmology Accelerate your product development with Ora For over 40 years, Ora has been on the leading edge of ophthalmic product development. We have a track record for accelerating development timelines and have helped our clients garner 52 FDA approvals. Let’s work together to move your program forward. Get In Touch Ora Headquarters 300 Brickstone Square Andover, Massachusetts 01810 United States of America Contact Us tel: (978) 685-8900 fax: (978) 689-0020 Stay in Touch Follow us on social media Copyright © 2020 Ora, Inc. All Rights Reserved. Privacy Policy Site Map Contact Us Ora, Inc websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and their use, please see our Privacy Policy. CONTINUE